亚太消融设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

亚太消融设备市场按类型、应用(普通外科、心血管疾病治疗、癌症治疗、眼科治疗、妇科治疗、泌尿科治疗、整容手术等)、最终用户和地理细分。

市场快照

Market Snapshot1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 7.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计亚太消融设备市场在预测期内的复合年增长率将接近 7.6%。癌症和心脏病等疾病的发病率不断上升,预计将增加对消融手术的需求。设计高端产品的技术进步和对微创治疗程序的需求不断增长,预计也将推动消融技术市场。此外,具有更高目标疾病风险的老龄化人口数量不断增加是推动消融手术需求的另一个重要因素。

日本是世界上人口老龄化速度最快的国家。根据《2019 年世界老龄化报告》,预计 2019 年日本 65 岁以上人口数量为 3552.4 万(28%),预计 2030 年将达到 3727.8 万(30.9%)。预计未来几年老年人口将增加,他们更容易患癌症、心血管疾病和泌尿系统疾病等慢性疾病,预计在不久的将来会增加消融手术,这对市场产生积极影响。

此外,根据世界卫生组织 (WHO) 的数据,2014 年约有 361,400 人死于癌症。然而,世界卫生组织 2018 年的统计数据表明,日本死于癌症的人数增加到近 409,400 人。

因此,癌症和其他慢性病的患病率上升预计将在预测期内显着增长。然而,严格的监管框架导致产品发布的酝酿期增加,这也是阻碍市场增长的市场挑战。

Scope of the report

As per the scope of the report, ablation generally refers to the removal of a part of biological tissue, usually by surgery. Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers. The Asia-Pacific Ablation Devices market is segmented by technology, application, end-User, and geography.

By Device Technology
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Other Devices
By Application
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Other Applications
By End-Users
Hospitals
Ambulatory Surgical Centers
Other End-Users
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

癌症治疗板块有望在亚太消融器械市场占据重要市场份额

多年来,印度的癌症患病率一直在上升。根据世界卫生组织 (WHO) 的数据,2014 年印度有 683,800 人死于癌症。据报道,这个数字在 2018 年增加到近 785,000 人。报告还指出,子宫颈癌是导致癌症的第二大原因。妇女死亡,是印度总体死亡的第三大原因。

此外,澳大利亚癌症委员会指出,癌症是澳大利亚死亡的主要原因。根据理事会的数据,2019 年澳大利亚有近 50,000 人死于癌症。

因此,由于癌症患病率的增加,预计该细分市场在预测期内将出现高增长率。

APAc ablation key trend 1.png

竞争格局

亚太消融设备市场竞争适度,由几个主要参与者组成。雅培、AtriCure 公司、波士顿科学公司、康梅德公司、强生公司、美敦力公司、奥林巴斯公司、施乐辉公司等公司在亚太消融设备市场占有相当大的市场份额。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Prevalence of Chronic Diseases

      2. 4.2.2 Emergence of Next-generation Ablation Products and Technology

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Device

      2. 4.3.2 Lack of Awareness and Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device Technology

      1. 5.1.1 Radiofrequency Devices

      2. 5.1.2 Laser/Light Ablation

      3. 5.1.3 Ultrasound Devices

      4. 5.1.4 Cryoablation Devices

      5. 5.1.5 Other Devices

    2. 5.2 By Application

      1. 5.2.1 Cancer Treatment

      2. 5.2.2 Cardiovascular Disease Treatment

      3. 5.2.3 Ophthalmologic Treatment

      4. 5.2.4 Gynecological Treatment

      5. 5.2.5 Urological Treatment

      6. 5.2.6 Cosmetic Surgery

      7. 5.2.7 Other Applications

    3. 5.3 By End-Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 Asia-Pacific

        1. 5.4.1.1 China

        2. 5.4.1.2 Japan

        3. 5.4.1.3 India

        4. 5.4.1.4 Australia

        5. 5.4.1.5 South Korea

        6. 5.4.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 AtriCure, Inc.

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Conmed Corporation

      5. 6.1.5 Johnson and Johnson (Biosense Webster, Inc)

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 Olympus Corporation

      8. 6.1.8 Smith & Nephew PLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The APAC Ablation Devices Market market is studied from 2018 - 2026.

The APAC Ablation Devices Market is growing at a CAGR of 7.6% over the next 5 years.

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Conmed Corporation, Olympus Corporation are the major companies operating in APAC Ablation Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!